We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Renewal of EAMS scientific opinion issued to Santhera Pharmaceuticals for Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy, including the public assessment report.
EAMS scientific opinion issued to Roche Products Limited for Risdiplam 0.75 mg/ml powder for oral solution in the treatment of type 1 and type 2 Spinal Muscular Atrophy (SMA) in patients 2 months and older who are not suitable for...
Accord Healthcare have informed us of an error with the patient information leaflets (PILs) that have been packaged in some Rosuvastatin products.
2.7 million vulnerable individuals in England to be offered free winter supply of vitamin D by the government.
First published during the 2019 to 2022 Johnson Conservative government
The Business Schools Task Force report recognises that there is a lot of good work already being done but issues a call to action to help mid…
First published during the 2010 to 2015 Conservative and Liberal Democrat coalition government
Lupin Healthcare (UK) Limited has informed us that the affected batches of Simvastatin tablets have been packaged with a version of patient information leaflet that does not include the most up to date safety information.
Review will look into potential options of dietary supplements and fortified food and drinks.
People who take stimulant laxatives for constipation are being advised that these will now be sold in smaller packs, with on-pack warnings.
A UK experiment to find new ways of creating materials to be used for medicines and metal alloys launched to the International Space Station (ISS).
Following a comprehensive scientific safety review of the latest available data on the safety of pholcodine, together with advice from the independent Commission on Human Medicines, it has been concluded that the potential risks outweigh the benefits for these products.
Latest data from the UK Health Security Agency (UKHSA) on scarlet fever and invasive group A streptococcus cases.
The lives of thousands of severely disabled people across England will be enhanced by 120 new changing facilities.
First published during the 2022 to 2024 Sunak Conservative government
Employment Tribunal decision.
Funding will improve access for people who cannot use standard accessible toilets and their carers.
New evidence review concludes that adults should do strengthening and balancing exercises twice a week alongside aerobic exercise.
We want to remind healthcare professionals that use of systemic (oral and injectable) NSAIDs such as ibuprofen, naproxen, and diclofenac is contraindicated in the last trimester of pregnancy (after 28 weeks of pregnancy).
UK's Chief Medical Officers publish first ever guidelines on physical activity for disabled children and young people.
Upper Tribunal Administrative Appeals Chamber decision of Judge Poynter on 15 October 2020
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).